Reviewed,
UniProtKB/Swiss-Prot O43318 (M3K7_HUMAN)
Last modified
December 16, 2008.
Version 93.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Mitogen-activated protein kinase kinase kinase 7 EC=2.7.11.25 Alternative name(s): Transforming growth factor-beta-activated kinase 1 Short name=TGF-beta-activated kinase 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 606 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Component of a protein kinase signal transduction cascade. Mediator of TGF-beta signal transduction. Stimulates NF-kappa-B activation and the p38 MAPK pathway. Ref.9 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Cofactor | Magnesium. |
| Subunit structure | Binds both upstream activators and downstream substrates in multimolecular complexes. Interacts with MAP3K7IP1 and MAP3K7IP2. Interacts with PPM1L. Interaction with PP2A and PPP6C leads to its' repressed activity. Ref.9 Ref.5 Ref.6 Ref.7 Ref.8 Ref.11 |
| Post-translational modification | Association with MAP3K7IP1 promotes autophosphorylation and subsequent activation. Dephosphorylation at Thr-187 by PP2A and PPP6C leads to inactivation. |
| Sequence similarities | Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily. Contains 1 protein kinase domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| IKBKAP | O95163 | 1 | EBI-358684,EBI-347559 | |
| MAP3K14 | Q99558 | 1 | EBI-358704,EBI-358011 | |
| MAP3K7IP2 | Q9NYJ8 | 1 | EBI-358684,EBI-358708 | |
| PELI3 | Q8N2H9-1 | 1 | EBI-358684,EBI-448466 | |
| PELI3 | Q8N2H9-2 | 1 | EBI-358684,EBI-448472 | |
| STAT3 | P40763 | 1 | EBI-358684,EBI-518675 | |
| Stat3 | P42227 | 1 | EBI-358684,EBI-602878 | From a different organism. |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1B (identifier: O43318-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 1A (identifier: O43318-2) The sequence of this isoform differs from the canonical sequence as follows: 404-430: Missing. | ||||||
| Isoform 1C (identifier: O43318-3) The sequence of this isoform differs from the canonical sequence as follows: 509-518: PLAPCPNSKE → ARTSCRTGPG 519-606: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 606 | 606 | Mitogen-activated protein kinase kinase kinase 7 | PRO_0000086252 | |||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 36 – 291 | 256 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 42 – 50 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 8 – 14 | 7 | Poly-Ser | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 156 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 63 | 1 | ATP | ||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 184 | 1 | Phosphothreonine; by autocatalysis Probable | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 187 | 1 | Phosphothreonine; by autocatalysis Probable | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 192 | 1 | Phosphoserine; by autocatalysis Probable | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 389 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 439 | 1 | Phosphoserine Ref.14 Ref.10 Ref.12 Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 404 – 430 | 27 | Missing in isoform 1A. | VSP_004886 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 509 – 518 | 10 | PLAPCPNSKE → ARTSCRTGPG in isoform 1C. | VSP_004887 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 519 – 606 | 88 | Missing in isoform 1C. | VSP_004888 | |||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 63 | 1 | K → W: Loss of kinase activity Ref.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 33 – 35 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 43 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 46 – 55 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 58 – 64 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 70 – 83 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 92 – 95 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 97 – 100 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 101 – 105 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 112 – 117 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 119 – 123 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 127 – 145 | 19 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 148 – 150 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 159 – 161 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 162 – 165 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 166 – 169 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 173 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 198 – 201 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 209 – 224 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 228 – 232 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 236 – 244 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 257 – 266 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 271 – 273 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 277 – 287 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 288 – 290 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 312 – 314 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism." Sakurai H., Shigemori N., Hasegawa K., Sugita T. Biochem. Biophys. Res. Commun. 243:545-549(1998) [PubMed: 9480845] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A; 1B AND 1C). Tissue: Lung. |
| [2] | NHLBI resequencing and genotyping service (RS&G) Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed: 14574404] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A). Tissue: Uterus. |
| [5] | "TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction." Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E., Matsumoto K. Science 272:1179-1182(1996) [PubMed: 8638164] [Abstract] Cited for: INTERACTION WITH MAP3K7IP1. |
| [6] | "Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1." Sakurai H., Miyoshi H., Mizukami J., Sugita T. FEBS Lett. 474:141-145(2000) [PubMed: 10838074] [Abstract] Cited for: INTERACTION WITH MAP3K7IP1, PHOSPHORYLATION AT THR-184; THR-187 AND SER-192, ACTIVATION. |
| [7] | "Pellino2 activates the mitogen activated protein kinase pathway." Jensen L.E., Whitehead A.S. FEBS Lett. 545:199-202(2003) [PubMed: 12804775] [Abstract] Cited for: INTERACTION WITH PELI1 AND PELI2. |
| [8] | "Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein." Jensen L.E., Whitehead A.S. J. Immunol. 171:1500-1506(2003) [PubMed: 12874243] [Abstract] Cited for: INTERACTION WITH PELI3. |
| [9] | "Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3." Edlund S., Bu S., Schuster N., Aspenstroem P., Heuchel R., Heldin N.E., ten Dijke P., Heldin C.H., Landstrom M. Mol. Biol. Cell 14:529-544(2003) [PubMed: 12589052] [Abstract] Cited for: FUNCTION, INTERACTION WITH SMAD7; MAP2K3 AND P38 KINASE, MUTAGENESIS OF LYS-63. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, MASS SPECTROMETRY. Tissue: Epithelium. |
| [11] | "Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway." Kajino T., Ren H., Iemura S., Natsume T., Stefansson B., Brautigan D.L., Matsumoto K., Ninomiya-Tsuji J. J. Biol. Chem. 281:39891-39896(2006) [PubMed: 17079228] [Abstract] Cited for: INTERACTION WITH PP2A AND PPP6C, DEPHOSPHORYLATION AT THR-187 BY PP2A AND PPP6C. |
| [12] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, MASS SPECTROMETRY. Tissue: Platelet. |
| [13] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, MASS SPECTROMETRY. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., |

Clusters with